Anle138b

CAS No. 882697-00-9

Anle138b ( —— )

Catalog No. M20225 CAS No. 882697-00-9

Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 30 In Stock
5MG 47 In Stock
10MG 80 In Stock
25MG 174 In Stock
50MG 259 In Stock
100MG 386 In Stock
200MG 556 In Stock
500MG 869 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Anle138b
  • Note
    Research use only not for human use.
  • Brief Description
    Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease.
  • Description
    Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    882697-00-9
  • Formula Weight
    343.17
  • Molecular Formula
    C16H11BrN2O2?
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:50 mg/mL?(145.70 mM)
  • SMILES
    C1OC2=C(O1)C=C(C=C2)C3=CC(=NN3)C4=CC(=CC=C4)Br
  • Chemical Name
    5-(13-Benzodioxol-5-yl)-3-(3-bromophenyl)-1H-pyrazole

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wagner J et al. Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease. Acta Neuropathol. 2013 Jun;125(6):795-813.
molnova catalog
related products
  • 11-Methoxyyangonin

    11-Methoxyyangonin is a natural kavalactone.

  • Skullcapflavone II

    Skullcapflavone II is a flavonoid derived from Scutellaria baicalensis, a widely used herbal medicine in anti-inflammatory and anticancer therapy.?

  • Palomid 529

    Palomid 529 has been used in trials studying the treatment of Age-Related Macular Degeneration.